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1. Introduction  
Visceral Leishmaniasis (VL) is an important Zoonosis, caused by Leishmania spp. protozoa. 
VL is commonly present in tropical countries, due its complex epidemiological 
characteristics that involve environmental and climatic conditioning factors; phlebotomine 
vectors and several species of domestic and wild animals. These aspects determine high 
difficulty for the disease control.  
VL is considered the second most important protozoosis and one of the six main infectious-
parasitary diseases in the world (WHO). However, VL is a neglected disease that occurs in 
80% of poor or miserable populations witch survive with less than two dollars per day 
(Desjeux, 2004). VL is considered an emergent/re-emergent Zoonosis with high mortality 
levels, with continuous and serious impact on Public Health. 
2. Epidemiology 
2.1 Definition and etiology 
Visceral leishmaniasis (VL) is a worldwide zoonotic disease caused by flagellar protozoa 
(family Trypanosomatidae, order Kinetoplastida, genus Leishmania (L. donovani complex) 
(Farrel et al., 2002). L. chagasi is frequently reported in Americas (New World), genetically 
similar to L. infantum that is found in some countries of Mediterranean and Asia. L. infantum 
/ L. donovani are the more prevalent species in Europe, Asia and Africa (Old World).  
2.2 Distribution and classification 
The VL origin in the New World is controversial. L. chagasi may be carried out by wild dogs 
some millions years ago, but some researches appoint that L. infantum may be disseminated 
after the European colonization. In a study of evolutive and geographical history of L. 
donovani complex, using specific molecular tests, it was possible to infer that L. (L.) chagasi 
and L. (L.) infantum are, in fact, different denominations of the same parasite specie, 
considering their molecular and biochemical similarity (Luke et al., 2007). It was possible to 
suggest that the primordial lineage of Leishmania spp. could be originated in South America. 
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VL was initially described in Greece, in 1835, and was called “ponos” or “hapoplinakon”. 
The denomination “calazar” is proceeding from India, which means “black skin” due the 
clinical characteristic presented in severe cases of infection (Lainson et al, 1987).  
VL is classified according to its clinical characteristics and epidemiology in five types: 
Indian, African, Mediterranean, Chinese and American. The Indian type is considered an 
antropozoonosis caused by L. donovani, mainly identified in children, adolescents and 
adults determining frequent outbreaks with high mortality levels. This VL type occurs in 
Afghanistan, Iran, Iraq, Jordan, Israel, Lebanon, Oman, Saudi Arabia, Syrian, Yemen and 
Bengala. The African type, similar to the Indian one, considering the susceptibility and 
clinical signs, is caused by L. donovani or L. infantum. The transmission areas of African 
type are next to forests. The Mediterranean type is a zooantroponosis mainly transmitted in 
the near-house place. This type is frequently identified in children with five year of age or 
less, and dogs. L. infantum is involved and also participates on the wild cycle infecting foxes 
and coyotes. It occurs in Mediterranean, the Middle East and the South of Russia. The 
Chinese type is another one antropozoonosis caused by L. infantum that complete its 
biological cycle in dogs, raccoons, coatis, and in children of China. The American type is an 
antropozoonosis in urbanization process. L. chagasi is enrolled predominantly in children of 
15 years of age or less, being transmitted by Lutzomyia longipalpis. In Colombia, Lutzomyia 
evansi is considered a secondary vector. In Latin America, VL is present in 12 countries with 
90% of cases occurring in Brazil. Great urban centers and capitals are being invaded by VL, 
including Belo Horizonte, Teresina, São Luís, Fortaleza and Rio de Janeiro, where 
autochthon cases are registered.  
First VL human case in Brazil was reported in 1913, when Migone identified amastigotes 
forms in necropsy materials collected from a man from Boa Esperança, Mato Grosso state 
(Brasil, 2006). Until the 90`s, the main reported VL cases in human were from Northeast 
states. However, the recent and fast VL expansion to the Southeast, Midwest and North 
states has being verified. Northeast states presented the greatest number of VL cases in 2001 
(81.7%), followed by North regions (8.8%), Southeast (7.6%) and Midwest (1.9%). However, 
in 2003, the disease was reported in 58%; 15%; 7% and 19% of the Northeast; North; 
Midwest and Southeast states, respectively, demonstrating VL urbanization in Brazil (Silva 
et al., 2001b; Lindoso & Goto, 2006). 
Canine visceral leishmaniasis (CVL) prevalence is also high in Brazil, ranging 1% to 36% 
according to Brazilian region (Silva et al., 2001b). Araçatuba was the first city in Sao Paulo 
state where CVL was diagnosed (Luvizotto et al., 1999). Forty one cities in Sao Paulo state 
present the CVL transmission, and human VL transmission was reported in 28 cities, with 
10% to 15% prevalence levels (Camargo-Neves, 2005). 
2.3 Vectors 
The vectors related with Leishmania dispersion are phlebotomines (mainly Lutzomyia 
longipalpis). Fleas and ticks are considered other possible leishmaniasis vectors. Reservoirs 
are infected by phlebotomine females biting during its blood feeding in the skin or the 
peripheral blood of the reservoirs (mainly in dogs).  
In Brazil, the main country of VL transmission in Latin America, the vectors L. longipalpis or 
L. cruzi are enrolled on disease transmission.  
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Phlebotomines are small size insects (3-5 mm lenght) and present a straw coloration. They 
multiply on organic materials like humid soil, leaves, manure, etc. The action area of 
phlebotomines is of 150-300 meters (300-600m diameter). They usually fly in small salts and 
when the females are blood feeding, they keep their flies erect.  
2.4 Reservoirs 
The direct transmission (person-to-person) of VL is rare. In regions of the New World, 
where L. chagasi is endemic, the infection dispersion/maintenance in human beings had 
been also attributed to the canine reservoirs. They live closely to human and attract the 
vector to human houses. Dogs present elevate subcutaneous parasitism levels with high 
infectivity to the VL vector. The infectivity levels for phlebotomines are similar in 
asymptomatic and symptomatic dogs (Zivicnjak et al., 2005). 
On the other hand, Leishmania can be also identified in wild animals as foxes (mainly 
Lycalopex vetulus and Cerdocyon thous) (De Lima et al., 2006), and opossums (Didelphis 
albiventris) (Santiago et al., 2007). Equines, cats and rodents have been also identified as 
reservoirs.  
Cats are susceptible to both VL and integumentary leishmaniasis. Xenodiagnosis studies 
with experimental Leishmania infections in cats demonstrated the evidence of feline`s 
infectivity to the vector L. longipalpis. Skin lesions and protozoan distribution in organs were 
verified in infected cats, but the disease was self-limited after few months post-infection. 
Cats’ eclectic habit as well as the vectors adaptation to different animal species would be 
favorable factors for VL transmission (Dantas-Torres et al., 2006). 
VL in cats may be also associated with immunosuppressive diseases such as leukemia and 
feline immunodeficiency. Recent studies are been developed in order to investigate the real 
feline role on VL epidemiology: if they are important reservoirs or only accidental hosts.  
2.5 Leishmania life cycle 
Infected vertebrate hosts (reservoirs) are bitted by phlebotomine vectors during the blood 
feeding. Vectors acquire macrophages containing Leishmania amastigotes forms which 
multiply by binary division. Amastigotes differentiate to promastigote (flagellar) forms 
which colonize vectors` pharynges and esophagus and stay adhered to epithelium by their 
flagella. Then, these promastigotes forms differentiate to metacyclical promastigotes 
(infecting) forms.  
Biological cycle is completed when vectors bite new vertebrate hosts and the infecting 
Leishmania forms are inoculated in the hosts` epidermis and phagocyted by macrophages. 
After phagocytosis, promastigotes change to amastigotes which intensively multiply by 
binary division. Macrophages become devitalized and break and release the amastigotes 
which are phagocyted by new macrophages in a continuous process. The haematogenic and 
lymphatic dissemination of protozoa for other tissues and organs occurs especially in 
mononuclear phagocytical system cells (Ikeda-Garcia & Marcondes, 2007).   
2.6 Characteristics and risk factors 
VL has been considered as a re-emergent disease in some countries and has assumed a new 
profile due economic and social changes in the two last decades. Initially, VL was 
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considered a typical and sporadically agricultural disease (Nunes et al., 2001). It reached 
dogs and human beings that lived in close contact with forest regions (Gontijo & Melo, 
2004). However, VL has been pointed currently as a re-emergent zoonosis, characterizing a 
clear process of epidemiological transition. LV has become an urban endemic disease that 
represents serious problems for Public Health due its zoonotic potential. The frequent 
deforestation has reduced the availability of original wild animals to vector. Then, dogs and 
human actually represents alternative sources for vector`s feeding (Desjeaux, 2004). 
This zoonosis has demonstrated an increased prevalence in recent years, not only 
considering the number of registered cases, but also regarding its geographic distribution. 
The important social, political and environmental damages (Fig. 1), added to continuous 
population migrations for urban centers without sanitary structure (Fig. 2) and lack of 
educative programs, associated to the easy vector adaptability to new environments and to 
the high population of dogs which are potential reservoirs, had contributed to establish 
favorable conditions to the VL urbanization (Camargo-Neves, 2005). Reduction of the 
disease ecological space is also verified, leading to important outbreaks.  
 
 
Fig. 1. Environmental damage caused by houses building in Botucatu, Sao Paulo State, 
Brazil. The human changes in natural areas, the vector adaptation and the high number of 
possible reservoirs species represent a serious VL transmission risk to human and animals.  
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Fig. 2. Organic material accumulation near to a house in Sao Manuel, Sao Paulo State, Brazil. 
This situation may represent a risk for vector multiplication and VL transmission to both 
human and animals, especially in tropical countries.  
2.7 Susceptibility 
People of both sexes and all ages are susceptible to VL. However, the incidence is 
highlighted in children with nine years of age or less, and in immunossupressed 
individuals. On the other hand, in recent endemic areas, a new situation regarding VL 
susceptibility has been observed, and the number of VL cases in children and adults is 
practically the same. This fact could be related to the protozoa`s pathogeny/pathogenicity 
variations and also to immunossupressor influences which adult persons are continuously 
exposed, like stress. 
Approximately 12 million of people in the world are infected by Leishmania and about 1.5-2 
million new cases (25-50% as VL type) are notified by year. However, the official data does 
not represents the real number of cases, due passive detections, under-diagnosticated cases, 
asymptomatic cases and low number of countries with obligatory notification (only 32 of 88 
endemic countries demand obligatory cases registration). In accordance with the Regional 
Program of Leishmaniasis, all American countries registered more than 5,000 VL cases in 
2006.  
3. Clinical signs in human and treatment 
The incubation period of VL in human is variable, ranging from 10 days to 24 months, with 
average of two to six months. Clinical manifestations of the disease in humans are presented 
gradually, starting with apathy, weight loss, anemia, fever and lymphadenopaty, and liver 
and spleen enlargement. Pneumonia and other severe manifestations due secondary 
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bacterial infections are also related. VL can be lethal in approximately 95% of cases without 
treatment (Murray et al., 2005).  
Treatment of human cases also is recommended as VL control method. The pentavalent 
antimonial substances (sodium estibogluconate and N-metil glucamine antimoniate) are the 
election drugs for use in humans, since 70 years ago. In India, where 50% of the VL cases 
occur, the miltefosin is being used - since March of 2002 – administered by oral route, also 
indicated in oncology. This drug presents relatively efficient safety and allows up to 98% of 
cure. It is indicated in refractory cases to the therapy with conventional antimoniates. 
However, the patients can develop gastric, intestinal and theratogenic collateral effects. 
Amphotericin B is another therapeutic option that also determines collateral effects and is 
considered a high cost drug. 
4. HIV-VL co-infection 
More than 30 million people in the world are infected by HIV, and at least one third of this 
population lives in leishmaniasis endemic areas (WHO). The overlapping of geographic 
areas where leishmaniasis and HIV occur is due to the process of urbanization. 
In Europe, 70% of LV cases in adults are associated with HIV, and more than 9% of the 
individuals with AIDS suffer a just acquired or reactivated leishmaniasis. Users of 
intravenous drugs are considered of high risk for the co-infection, by sharing needles. From 
80’s on, this co-infection started to be described in the Europe, particularly in Spain, Italy 
and South France. In people infected by HIV, leishmaniasis presents severe clinical 
manifestations and determines lethal immunosuppressive synergism with HIV with 
stimulation of the viral response. However, the opportunistic behavior of Leishmania on 
HIV-VL co-infection is still not clear.  
The HIV-VL co-infection is considered a world priority by WHO. In this context, it was 
established a worldwide network of further notification of cases.  
5. Clinical signs in dogs 
Canine Visceral Leishmaniasis (CVL) determines a chronic systemic disease with several 
clinical manifestations, with difficult diagnosis. CVL incubation period is variable. Clinical 
signs can be verified in dogs between three months to various years after infection (mean 
three to seven months) (Brasil, 2006). 
Lymphadenopathy; abdominal distension due liver and spleen enlargement; skin lesions 
and/or alopecia (Fig. 3); emaciation; apathy; ocular lesions (Fig. 4); onicogryphosis; 
haemorrhages; diarrhoea and pneumonia are the main clinical signs reported. Locomotors 
and neurological alterations are occasionally related (Slappendel & Ferrer, 1998). 
Clinical signs in dogs may have different presentations, depending on the region (Cruz, 
2006; Duprey et al., 2006; Albuquerque et al., 2007). In a recent study, the main clinical 
manifestations observed in 100 examined dogs from an endemic VL area in Brazil were: 
emaciation (60%); spleen enlargement (57%); alopecia (51%); ocular lesions (46%); skin 
ulcers (43%); liver enlargement (38%); onicogryphosis (37%) and lymphadenopaty (21%) 
(Troncarelli et al., 2008). 
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Symptomatic CVL is frequently reported, but asymptomatic cases represent about 60% of 
infected dogs. Asymptomatic parasited dogs with or without antibodies have been 
identified in natural and experimental infections (Farrel, 2002).The infected asymptomatic 
animals represent a serious problem for public health because they are important 
unidentified reservoirs. On the other hand, when an infected asymptomatic dog is 
diagnosed, control measures may be difficult because the euthanasia is usually not 
authorized by dog’s owner. 
 
 
(A) (B) 
 
Fig. 3. Symptomatic VL seropositive dogs in the Zoonosis Control Center (ZCC) in Bauru – 
an important VL endemic area of Sao Paulo State, Brazil. A: alopecia, emaciation, skin 
lesions, onicogriphosis and apathy. B: lymphadenopathy (popliteal), emaciation, 
dehydratation. 
 
   
(A)            (B) 
 
Fig. 4. Symptomatic VL seropositive dogs from Bauru, Sao Paulo State, Brazil. A: severe 
periocular, nasal and auricular skin lesions (humid dermatitis, alopecia, crusts and 
secondary bacterial infection). B: ocular lesions, jaundice. 
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6. Diagnosis 
6.1 Dogs 
Considering that VL is a further notification zoonosis and reinforcing the risks to public 
health represented by Leishmania infected dogs, CVL diagnosis must be the more accurate 
than possible. It is important that the technical groups involved on CVL diagnosis 
specifically know about the available tests, as its limitations and clinical interpretation (Luz 
et al., 2001; Gradoni, 2002; Ikeda-Garcia & Marcondes, 2007). 
The diagnosis result must not be individually analyzed. There are various dependent factors 
that must be evaluated, like epidemiological issues, clinical signs, laboratory diagnosis 
results, etc. A positive result, if punctually analyzed, can condemn a non-infected dog to the 
euthanasia and a negative result if not correctly evaluated can contribute to the maintenance 
of an infected dog as a Leishmania reservoir (Machado, 2004; Zivicnjak et al., 2005).    
6.1.1 Serology 
Detection of circulating antibodies anti-Leishmania spp. in dogs by serological tests is an 
essential tool for CVL diagnosis. Serum samples or eluted blood samples can be examined 
by serological tests (Fig. 5).  
Dogs generally present seroconvertion after three months post-infection. Antibodies titles 
remain high for at least two years after Leishmania infection (Ikeda-Garcia & Marcondes, 
2007). CVL clinical signs and antibodies titers are not necessarily dependent factors (Reis, 
2001; Ferreira et al., 2007).  
Available serological tests commonly used for CVL diagnosis are Indirect 
Haemagglutination (IHA); Agglutination in Latex (AL); Direct Agglutination (DA); 
Immunoeletrophoresis; Indirect Immunofluoresence Antibody Test (IFAT) (Fig. 5); Enzyme-
linked Immunosorbent Assay (ELISA); Complement Fixation; Immunoprecciptation in gel 
and Western blot. Brazilian Health Ministry (Brasil, 2006) determined that the official labs 
must apply ELISA as a selection diagnosis and IFAT as a confirmatory test, in CVL 
surveillances. 
IFAT usually shows high sensitivity and specificity values, ranging from 68 to 100% and 74 
to 100%, respectively (Grosjean et al., 2003; Alves & Bevilacqua, 2004). ELISA` sensitivity 
and specificity values range from 71 to 100% and 85 to 100%, respectively. These tests are 
feasible, fast and inexpensively executed (Ikeda-Garcia & Marcondes, 2006). However, a 
positive result may not represent an active disease and also infected dogs may have 
negative results by serological tests. Two tests with 21-30 days interval are recommended. 
Due to the phylogenetic similarity between Leishmania genus and Trypanosoma cruzi (T. 
cruzi), serological cross-reactions (Fig. 6) and false-positive results are quite common 
(Zanette et al., 2006). There are endemic areas, especially in the Americas, where Leishmania 
spp. and T.cruzi incidences are superposed and co-infection with the two parasites may 
occur both in dogs and in human beings (Savani et al., 2005; Madeira et al., 2006). In fact, the 
results from serological tests may show Leishmania spp. and T.cruzi antibodies, signifying 
the occurrence of infection by the two parasites, rather than cross-reactions (Grosjean et al., 
2003; Rosypal et al., 2007). By this way, the improvement of diagnosis methods for the 
correct identification of canine infection is necessary to better comprehend the disease’s 
status in dogs and also to contribute to its control. 
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Fig. 5. Blood sampling for CVL serological diagnosis at Zoonosis Control Center (ZCC) of 
Bauru, Sao Paulo State, Brazil.  
    
(A) (B) 
Fig. 6. Positive results for Leishmania spp. and Trypanosoma cruzi by indirect 
immunofluorescence tests in serum samples collected from a dog in an VL endemic area in 
Brazil. Note the morphologic similarity between the protozoan parasites. A: promastigotes 
forms of L. major. B: trypomastigotes forms of T. cruzi “Y”strain. Pictures credits: Zoonosis 
Research Nucleous (NUPEZO), Univ Estadual Paulista (UNESP), Botucatu, Sao Paulo, Brazil. 
A 16.5% (33/200) cross-reaction between Leishmania spp. and T.cruzi in blood samples 
collected from dogs in an endemic VL area in Brazil was verified. Twenty-six (78.8%) of 33 
dogs that showed anti-Leishmania spp. and anti-T.cruzi antibodies also tested positive by 
direct parasitological examination and PCR for Leishmania spp., which indicates that these 
dogs presented leishmaniasis. No liver or spleen sample from the 200 dogs analyzed 
showed a positive PCR result for T.cruzi. These findings support the occurrence of cross-
reactions between Leishmania spp. and T.cruzi in IFAT; they also corroborate the need for 
simultaneous PCR and/or parasitological examination to establish canine leishmaniasis 
(CL) diagnosis. 
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On the other hand, it is important to reinforce that cross-reactions between Leishmania and 
other tripanosomatids or different microorganisms (including Ehrlichia canis; Babesia canis;, 
Toxoplasma gondii or Dirofilaria immitis) can occur, producing false-positive results (Rosario, 
2002; Luvizotto, 2003; Alvar et al., 2004). The use of recombinant or purified antigens (like 
gp63, gp72 and gp70; rK39, rK9 and rK26) improves the sensitivity and specificity of 
serological tests (Rosário, 2002; Zijlstra et al., 2001).  
6.1.2 Culture 
Blood samples and lymph node, bone marrow and spleen aspirates can be used for VL 
diagnosis by culture in special medium like Liver Infusion Tryptosis (LIT); NNN and RPMI-
1640 (Sundar & Rai, 2002).  
Leishmania amastigotes forms presented in original biological samples collected from 
vertebrate hosts modify to promastigotes (flagellar) forms in culture medium and can be 
visualized by optical microscope (Fig. 7). 
 
Fig. 7. Leishmania promastigotes forms isolated in Liver Infusion Tryptosis (LIT) medium 
after four weeks incubation at 27ºC. Optical microscopy 1000X.  
Culture diagnosis is commonly used for researches purposes because it is a time and 
material-consuming method. Results are lately obtained because Leishmania presents a slow 
multiplication in culture media. A positive result can be verified until four months post-
incubation, especially in case of low parasite load presented in biological collected samples. 
6.1.3 Parasitological identification 
6.1.3.1 Citology 
Leishmania amastigote forms can be visualized in lymph nodes squashes (or aspirate); bone 
marrow; spleen aspirate; skin biopsy; skin nodules aspirate; liver biopsy and blood 
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squashes. Giemsa, Leishman, Wright and Panotico are the most common dyes used (Sundar 
& Rai, 2002). Amastigotes forms have 2-5 µm size. For the correct diagnosis, it is necessary to 
observe three parasites` structures: cytoplasm, nucleous and kinetoplast (Fig. 8). 
 
Fig. 8. Dog`s liver imprint showing the protozoa`s amastigote structures. Giemsa dye, 1000X. 
A: amastigotes forms in a macrophage cytoplasm. B: individual protozoa`s amastigote form 
presenting cytoplasm, nucleus and kinetoplast. 
Aspirative cytology is generally used in vet clinics because it is a relatively easy and low 
invasive procedure. Citology sensitive values are directly related to parasite load, biological 
material collected, technical experience and time for slide examination (Ikeda-Garcia & 
Feitosa, 2006). This test presents sensitivity levels of 58%, 70% and 96%, for lymph node, 
bone marrow and spleen aspirates, respectively (Zijlstra et al., 2001). The 100% specificity 
allows the indication of cytology as a gold standard method. However, negative results are 
not uncommon, especially in chronic and/or asymptomatic CVL cases. 
6.1.3.2 Immunohistochemistry 
Skin, liver and lymphoid tissues are the election materials for VL diagnosis by 
immunohistochemistry/immunocytochemistry (IHC). Blood squashes; cytological slides; 
histological and frozen tissues can also be examined (Ikeda-Garcia & Feitosa, 2006). IHC 
allows retrospective studies and can be indicated for skilful exams.  
Immunoglobulins conjugated to enzymes are used to identify Leishmania amastigotes forms 
in tissues. High sensitivity and specificity values of this method allow an accurate and fast 
diagnosis despite the eventual low parasites load on samples (Ikeda-Garcia & Marcondes, 
2007). Amastigotes presents a hazel-brown coloration, easily visible by conventional optical 
microscopy. 
B 
A
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6.1.4 Molecular diagnosis 
Polymerase Chain Reaction (PCR) allows the parasite’s DNA detection and does not depend 
on the dog’s immunological and/or clinical status (Soares et al., 2005; Reithinger & 
Dujardin, 2007). PCR can be used in cases of inconclusive reactions, anergy or cross 
reactions in serological tests, and shows sensitivity and specificity values near 100% 
(Lachaud et al., 2002; Gomes et al., 2007). Blood samples (Silva et al., 2001a); lymph node 
aspirates; bone marrow aspirates; biopsy fragments (skin, liver, spleen, etc.) and any kind of 
biological material can be tested by PCR for Leishmania`s DNA search. 
Different PCR protocols have been studied for leishmaniasis diagnosis in animals (Strauss-
Ayali et al., 2004), human and vectors (Aransay et al., 2000). Primers used are usually 
Leishmania genus-specific (Fig. 9.) or specie-specific (Solano-Gallego et al., 2001). Detection of 
more than one Leishmania species can be obtained by multiplex PCR (mPCR) protocols 
(Lachaud et al., 2002a,b). Parasite load can be evaluated by real time PCR (qPCR) techniques 
(Nicolas et al., 2002). The association of molecular methods with conventional diagnosis 
tests for VL diagnosis allows an accurate evaluation and also contributes to epidemiological 
and genetic studies (Singh & Sivakumar, 2003; Moreira et al., 2007). 
PCR also contributes with diagnosis elucidation, especially in case of cross reactions results 
by serological tests. 93.9% sensitivity and 85.8% specificity levels were obtained by PCR for 
leishmaniasis diagnosis in spleen and liver fragments collected from dogs in Bauru, an 
endemic CVL area in Brazil (Troncarelli et al., 2009). Using the LINR4 and LIN19 
(Ikonomopoulos et al., 2006) primers it was possible to identify 30 of 33 Leishmania infected 
dogs that were both positive for Leishmania and T. cruzi by IFAT. 
 
Fig. 9. Leishmania spp. kDNA amplification by Polimerase Chain Reaction. Samples: spleen 
fragments collected from euthanized dogs from Bauru (a Visceral Leishmaniasis endemic 
area in Sao Paulo State, Brazil). Primers LIN19 and LINR4. Agarosis gel 2%. bp - base pairs; 
LD - DNA ladder; C+ positive control (L.major); 1,3,4,5,9,10 – positive samples; 7 – positive 
sample with high DNA concentration; 2,6,8,11 – negative samples; 12 – negative control 
(milliQ water); 13 – PCR negative control (MIX-PCR). 
6.2 Human 
VL human diagnosis is difficult, because it is generally based on clinical signs that are lately 
identified. VL is a chronic disease, with a long incubation period with gradual and slow 
clinical manifestations, in the main number of cases. Infected people just call for a doctor 
when clinical signs are evident like abdominal distension - due liver and spleen 
720 bp 
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enlargement, hypoproteinemia, anemia – besides progressive emaciation; pain; 
lymphadenopahty or other severe disorders. In these cases, the diagnosis is done, but the 
prognostic is reserved to bad, especially in case of young and/or immunossupressed 
patients (Brasil, 2006).  
Serology tests can be done, but results are questionable and normally do not depend on 
patient infection and/or clinical status. The intra-dermal reaction (Montenegro`s test) is 
usually negative in VL human cases during disease`s clinical course, but can be positive in 
asymptomatic individuals or after the clinical cure (Ikeda-Garcia & Marcondes, 2007).  
Culture of blood marrow aspirates and direct parasitological exam of blood marrow 
squashes are the main sensitive tests for human VL diagnosis, but sampling method is 
invasive and painful. Liver and spleen biopsy are not recommended, especially in chronic 
cases, due haemorrhages risks due organs enlargement caused by Leishmania infection.  
7. Epidemiological vigilance, prophylaxis and control 
Considering the difficulties of VL control and monitoring, actions are centered on the better 
definition of risk transmission areas. The new target is to reinforce vigilance measures in 
States and counties where no LV human or canine cases are related, in order to avoid or to 
minimize the disease transmission in these non endemic areas. In the VL endemic areas, 
after the epidemiological stratification, the control measures generally are individually 
evaluated and implemented. However, it is important that integrated measures are adopted 
for an effective control. 
VL incidence especially in Americas is very high, but control strategies must be improved. 
Surveillance systems are usually inadequate and there are no sufficient human resources for 
diagnosis, treatment and control methods implementation. The Regional Program 
supported by the Global Program on leishmaniasis prevention and control prepared an 
action plan to be started in 2007. This plan includes a collective work for diagnosis tests 
standardization; strengthening of human resources; decentralization of public health 
programs of VL prevention and control; surveillance system improvement; strategic 
partnerships development and communities` involvement.  
7.1 Vector control 
The control strategy of this zoonosis includes: the early identification/treatment of human 
cases, the residual insecticides spraying in domiciles and near-house areas and add physical 
barriers in doors and windows in order to prevent the exposition to the vector. Photo-stables 
pyrethroids are usually sprayed in the human houses’ walls, and animals’ installations, like 
hen and swine houses, stables, etc; considering that these animals and its organic substances 
attract phlebotomines. It is important to reinforce the adequate destination of garbage, the 
removal of rubbish and organic substances in the near-house areas. 
7.2 Control in dogs 
7.2.1 Euthanasia 
The identification of serologically positive dogs, followed by euthanasia (Fig. 10) is one of 
control measures adopted in endemic areas (Brasil, 2006). VL coexists in dogs and humans 
but generally the disease in dogs precedes the occurrence of human cases. This reinforces 
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the importance of fast diagnosis in dogs, especially in endemic areas. Dogs are considered 
competent and abundant reservoirs, and cohabit with humans.  
 
Fig. 10. Euthanasia of a symptomatic VL seropositive dog in Zoonosis Control Center (ZCC) 
in Bauru, Sao Paulo State, Brazil. Approximately 20-30 dogs are euthanized at the ZCC 
daily. 
The impact of the control by positive dogs’ elimination is very conflicting, because it is 
showing laborious, with doubtful effectiveness and for the veterinarians and owner’s point 
of view. The euthanasia of seropositive dogs is frequently discussed. In recent studies, the 
evolution of seropositivity levels in humans, in two areas - one with elimination and another 
one without elimination of the seropositive dogs – were evaluated and there was no 
significant difference after one year of serological monitoring. However, the risk to the 
domestic man and to other animals – considering the importance of dog as a reservoir, and 
the low efficiency of therapeutical protocols for dogs - justifies, until the moment, the 
recommendation for euthanasia of infected dogs, as complementary method of control and 
prophylaxis of VL. 
7.2.2 Collars with repellent substances 
Collars impregnated with deltamethrin or other repellent substance can be associated with 
other control measures for VL prevention in dogs. This measure avoids dogs to be bitted by 
the vector. 
A study done in Andradina (Camargo Neves, 2005), an endemic VL area in Sao Paulo State, 
Brazil, demonstrated that both CVL and human VL prevalences had decreased when a 
prevention program was initiated with deltamethrin collars putting in dogs. It is important 
to reinforce that collars were replaced each three to four months interval, in order to 
maintain the residual action of the repellent.  
7.2.3 Vaccination 
Vaccination is considered another control method of CVL. There are several studies 
regarding dogs’ immunization, and the main researches’ objective is to develop a safe, low 
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cost and highly immunogenic vaccine against VL in dogs.  In experimental studies, filtered 
proteins from Leishmania promastigotes culture stimulated high immunity in different hosts, 
and conferred good protection in BALB/c mice infected with L. major. In other research, it 
was demonstrated that the vaccine produced from promastigotes antigens of L. infantum 
allowed 92% of protection in dogs from endemic areas.  
The Fucose Manose Ligand (FML) was the first antigenic glycoprotein approved for dogs`s 
immunization in Brazil. The main question regarding this vaccine was the probable 
difficulties to differentiate naturally infected from vaccinated animals by conventional 
serological tests.  
A new recombinant vaccine using the A2 Leishmania antigen fragment was recently 
approved by Brazilian Ministry of Agriculture.  
National researches institutes in Brazil are also involved on CVL vaccines development. The 
main effort is to produce a recombinant CVL vaccine associated with Rabies virus, to be 
used in national vaccination programs.  
7.2.4 Treatment 
Treatment of dogs with drugs indicated for human application is not recommended in 
Brazil (Brasil, 2006). Despite several studies have been conducted demonstrating that clinical 
signals are minimized or eliminated after treatment, there are some controversies about the 
parasitological cure versus the apparent clinical cure. Some researches reinforce that dogs 
could remain as Leishmania reservoirs representing a public health risk. 
On the other hand, CVL treatment is allowed in Spain and in other endemic countries. 
Glucantime is sold for veterinary use, and the doses volume is adjusted for use in small 
animals. Moreover, there are some medical pet foods with low protein levels indicated for 
dogs with leishmaniasis, considering that CVL commonly determines hepatic and renal 
lesions by immune-complexes deposition. 
7.3 Control difficulties 
7.3.1 General factors 
One of the biggest challenges for the strategies control improvement is the identification of 
each element of the epidemiological chain and its impact on VL transmission. The high 
prevalence of VL in endemic areas, especially in tropical countries are due environmental 
and climatic changes; low financial support on Health and Education programs; 
discontinuing of control measures; vector’s adaptation to environments modified by human; 
vectors genetic variances; co-infection with immune-suppressor diseases like AIDS, or 
chemotherapy treatment; urban problems like under-nutrition, house lacking and sanitary 
deficiencies. 
7.3.2 Diagnosis fails 
The delay on human and canine VL diagnosis usually determines under-notification of cases 
and treatment fails. This may be determined by lack of information on VL by population 
and eventually by some health professionals contributing to VL severity increase, high 
mortality levels and dissemination risks. The time between sampling, diagnosis and control 
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measures is too long (more than 80 days), determining the maintenance of infected dogs as 
reservoirs during several months. The strategy of seropositive dogs culling after 80 days 
blood sampling and diagnosis reduces in 9% the VL prevalence. If the euthanasia of 
seropositive dogs is done after 7 days of sampling and diagnosis, there is a 27% reduction in 
seroprevalence.  
7.3.4 Vectors`characteristics 
Phlebotomines are highly adaptable insects. As they multiply in organic materials, its 
control is very hard. The use of insecticides must be done by official agents with extremely 
sense, due the insecticides` residues that can prejudice the ecosystem and the environment.  
It is also important to consider the potential of other species of insects and mites as VL 
transmitters.  
7.3.5 Reservoirs` characteristics  
Dog is generally considered a family member. Its close contact with human may represent a 
serious public health risk considering the VL transmission potential in endemic areas. In 
some situations, when an infected dog is identified by diagnosis methods, it is sent to 
another place by its owners, in order to avoid the dog`s euthanasia. As there is no control 
about dogs’ transit from endemic to non endemic areas, the risk of introduction and 
dissemination of VL in different regions is very high. 
It is also important to consider the reservoirs potential of wild animals as and the role of 
some domestic animals like cats on VL transmission.  
8. Continued education 
Continued education programs on VL are essential for population orientation and to 
establish directing global actions involving community and public health organs for the 
disease prevention and control. The educative actions must be implemented in schools and 
neighbor associations in order to provide information regarding the main VL clinical signs 
and the prevention methods. Responsible ownership must be emphasized because dogs’ 
replacement levels after infected dogs’ removal for euthanasia are extremely high, especially 
in VL endemic areas. 
9. Conclusion 
VL represents a serious Public Health challenge in the world. The high disease expansion 
both in number of cases and in geographic areas reinforces the necessity of effective VL 
monitoring and control strategies. The complexity of causal agent, the variability of 
reservoirs species and the vectors adaptability to different ecosystems demand systematic 
and integrated actions in different points of the epidemiological chain. These factors explain 
why leishmaniasis is an old disease with continuous impact on public health. 
The improvement of diagnosis methods, the surveillance studies, the vaccine 
immunoprophylaxy, the systematic control of vectors, the researches for effective 
antimicrobials and therapeutical protocols for dogs and humans, the continued education 
regarding VL and responsible ownership are some measures for the VL control success.  
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